User:GastroparesisGwen
Editor·10,744 edits·since 2024/10
GastroparesisGwen is an editor on PeptidePedia Wiki, editing since 2024 / 10.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
10,744Total edits
21Logged here
19Articles touched
2024/10Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| SURMOUNT trial programme | 2 | 33 | 6% |
| Adverse effects of GLP-1 receptor agonists | 2 | 44 | 5% |
| Cold chain | 1 | 44 | 2% |
| Qingdao Saber Technology Pharmaceutical | 1 | 28 | 4% |
| Chain of custody | 1 | 39 | 3% |
| Customs seizure | 1 | 39 | 3% |
| High-performance liquid chromatography | 1 | 37 | 3% |
| Shenzhen Hybio Pharmaceutical | 1 | 37 | 3% |
| Multi-dose vial | 1 | 31 | 3% |
| Trial data comparison | 1 | 35 | 3% |
| Fmoc chemistry | 1 | 39 | 3% |
| Shanghai ERP Biotechnology | 1 | 33 | 3% |
| Trifluoroacetate counterion | 1 | 37 | 3% |
| Weight regain after discontinuation | 1 | 33 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.